glp-1 weight loss drugs news today U.S. Obesity Rate Drops as Use of Surges | National GLP-1 Weight Loss Drugs May

Henney 2024) demonstrated a potentially meaningful reduction in incident pneumonia with GLP-1 RAs compared with dipeptidyl peptidase-4 (DPP-4) inhibitors (hazard ratio [HR] 0.60, 95% confidence interval [CI] 0.580.62

Due to a short plasma half-life of native GLP-1, several synthesized GLP-1 receptor agonists (RAs) were developed for type 2 diabetes mellitus (DM) treatment

Additionally, the nominal group technique was used to gather insights from medical experts from different areas regarding the combined therapys daily clinical use, concerns, and limitations

Find out how to verify it's FDA-approved and avoid compounded knockoffs that could put your health at risk.

But despite widespread use of these drugs by perimenopausal women, research has largely ignored the unique risks and potential opportunities for optimizing health that GLP-1s may pose for this population.

Turn ordinary foods into functional superfoods with GLP-1 Daily Support, a 4-in-1 prebiotic blend that naturally aids appetite control, blood sugar balance, and metabolic health